TP53 and medulloblastoma: Increased expression of TP73-AS1 has been associated with poor prognosis of TP53 wild-type SHH medulloblastoma patients, and its knockdown increases the apoptosis rate, decreases migration, reduces proliferation, and increases survival of animal models [59].